Recent posts

TypePostAuthorRepliesLast updated
Blog entryNational Association of Manufacturers told USTR the EU position on LDC extension made a mockery of international trading system thiru014 hours 3 min ago
Blog entryDifferences between the march-in, royalty free right, and government use options James Love01 day 4 hours ago
PageDiane Singhroy, Scientific and Technical Advisor Claire Cassedy02 days 12 hours ago
Blog entry500+ Pages of Documents on NFL Attempts to Influence NIH Funding of Concussion Studies Zack Struver03 days 10 hours ago
Blog entryNIH Waivers for U.S. Manufacturing Requirements for Federally-Funded Drugs Zack Struver04 days 7 hours ago
Blog entryKEI Statement on United Nations Secretary-General's High-Level Panel on Access to Medicines Report KEI Staff01 week 4 hours ago
Blog entryCancer Moonshot Blue Ribbon Panel Does Not Address Pricing, Alternative Funding Models Zack Struver01 week 6 hours ago
Blog entrySummary of Report of United Nations Secretary-General's High-Level Panel on Access to Medicines Zack Struver01 week 1 day ago
Blog entryTRIPS Council (October 2014): India calls for de-linkage and innovation inducement prizes at WTO discussions on IP & innovation thiru01 week 2 days ago
Blog entryWIPO Marrakesh Treaty for the blind to come into force September 30, 2016, following ratification by Canada James Love02 weeks 2 hours ago
Blog entryGerman Court Issues Compulsory License on HIV Drug Patent Andrew Goldman02 weeks 8 hours ago
Blog entryCommentary on Hillary Clinton's Plan to Respond to Unjustified Price Hikes for Long-Available Drugs Claire Cassedy02 weeks 2 days ago
Blog entryKEI Briefing Note 2016:2: 2015-2016 Pharmaceutical Transparency Legislation Zack Struver02 weeks 3 days ago
Book pagePublications and Research Notes James Love02 weeks 3 days ago
Blog entry2016: KEI/MSF comments to NIH on licensing of patents on Attenuated Respiratory Syncytial Virus (RSV) Vaccines James Love04 weeks 9 hours ago
PageAndrew S. Goldman, Counsel, Policy and Legal Affairs Claire Cassedy04 weeks 4 days ago
Blog entryHarvoni & Sovaldi, Xtandi in Top 20 Costliest Medicare Drugs Zack Struver06 weeks 9 hours ago
Blog entryBloomberg: CVS Will Exclude Xtandi From Formulary in 2017 Zack Struver07 weeks 3 days ago
Blog entryVivendi-SFR lobbyist nominated to WIPO Staff07 weeks 3 days ago
Blog entryProposal for a WTO Agreement on the Supply of Public goods KEI Staff08 weeks 8 hours ago
Blog entrySCP24:WIPO patent committee adopts robust work program on patents and health, limitations and exceptions and quality of patents thiru08 weeks 1 day ago
Blog entryLetter from 56 non-profits and experts to Secretary of State John Kerry on pressure on global access to medicines initiatives Zack Struver08 weeks 2 days ago
Blog entryWIPO GA 2013 to decide on future of the Intergovernmental Committee on Genetic Resources, Traditional Knowledge and Folklore thiru08 weeks 2 days ago
Blog entryHuman Rights Council adopts watershed resolution on Access to Medicines thiru09 weeks 4 days ago
Blog entryRoger Bate: Eclectic booster of corporate views thiru010 weeks 13 hours ago